Press Releases

Vancouver, British Columbia--(Newsfile Corp. - May 31, 2024) - Spanish Mountain Gold Ltd. (TSXV: SPA) (FSE: S3Y) (the "Company" or "Spanish Mountain Gold") is pleased to announce that, further to its news release dated May 27, 2024, it has closed the first tranche of the previously announced private placement (the "Private Placement") of flow-through units of the Company (the "FT Units") at a price of $0.24 per FT Unit and non flow-through units (the "NFT Units") at a... (continue reading...)

First of Five Short Films Chronicling Everyday Heroes in the AANHPI Community Premieres Friday, May 31, 2024

SAN FRANCISCO, May 31, 2024 /PRNewswire/ -- To continue celebrating Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage, The Asian American Foundation (TAAF) debuts the third annual television special of TAAF Heritage Heroes, which is comprised of five short films profiling everyday people making a difference in the AANHPI community. This... (continue reading...)

DENVER, May 31, 2024 /PRNewswire/ -- redT Homes, a pioneering residential real estate development firm in Denver, is thrilled to announce its prestigious win of the 2023 Xcel Energy Sustainable New Housing (ESNH) Program Award for Best Individual Electric Only Builder Overall. This accolade underscores redT Homes' unwavering dedication to sustainable living and eco-conscious construction practices.

... (continue reading...)

TEMPE, Ariz., May 31, 2024 /PRNewswire/ -- GoDaddy Inc. (NYSE: GDDY) today announced Go Daddy Operating Company, LLC and GD Finance Co, LLC (each, a subsidiary of GoDaddy Inc. and together, the "Borrowers") closed the previously announced credit agreement refinancing and extension. In connection with the closing, the Borrowers entered into an Eleventh Amendment (the "Eleventh Amendment") to the Second Amended and Restated Credit Agreement, dated as of February 15,... (continue reading...)

New formulation showed non-inferiority to intravenous administration in fourth positive Phase 3 study in RYBREVANT® clinical program

Longer overall survival, progression-free survival and duration of response shown with subcutaneous amivantamab; featured in Best of ASCO 2024

RYBREVANT® marketing application submitted to European Medicines Agency based on PALOMA-3 study

CHICAGO, May 31, 2024 /PRNewswire/ -- Johnson & Johnson announced today first data from the Phase... (continue reading...)